zolmitriptan has been researched along with Ache in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Best, C; Birklein, F; Döring, K; Krämer, HH | 1 |
| Assaid, C; Dodick, DW; Ho, TW; Kost, J; Lines, C | 1 |
| Dodick, DW; Ferrari, MD; Ho, TW; Kost, J; Lines, C; Olesen, J | 1 |
| Aubel, B; Bourgoin, S; Hamon, M; Kayser, V | 1 |
| Burstein, R; Collins, B; Jakubowski, M | 1 |
| Akguen, D; Baykal, O; Diener, HC; Katsarava, Z; Kaube, H; Limmroth, V | 1 |
| Charlesworth, B; Klapper, J; Lucas, C; Røsjø, Ø | 1 |
| Abu-Shakra, S; Adelman, J; Freitag, FG; Loder, E; Pearlmand, S | 1 |
| Goadsby, PJ; Hoskin, KL | 1 |
6 trial(s) available for zolmitriptan and Ache
| Article | Year |
|---|---|
Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Electric Stimulation; Female; Humans; Male; Migraine Disorders; Neurogenic Inflammation; Neurons, Afferent; Nociceptors; Oxazolidinones; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Serotonin Receptor Agonists; Skin; Tryptamines; Young Adult | 2015 |
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
Topics: Adult; Analgesics; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Pain; Research Design; Serotonin 5-HT1 Receptor Antagonists; Tryptamines | 2011 |
Antimigraine efficacy of telcagepant based on patient's historical triptan response.
Topics: Adult; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Pain; Surveys and Questionnaires; Tryptamines | 2011 |
Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blinking; Electrophysiology; Female; Humans; Male; Migraine without Aura; Oxazolidinones; Pain; Pain Measurement; Serotonin Receptor Agonists; Trigeminal Nerve; Tryptamines | 2004 |
Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Odds Ratio; Oxazolidinones; Pain; Prospective Studies; Time Factors; Tryptamines | 2004 |
Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pain; Placebos; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2005 |
3 other study(ies) available for zolmitriptan and Ache
| Article | Year |
|---|---|
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Nerve Diseases; Tryptamines | 2002 |
Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
Topics: Administration, Oral; Adolescent; Adult; Humans; Injections; Middle Aged; Migraine Disorders; Oxazolidinones; Pain; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Skin; Sumatriptan; Time Factors; Triazoles; Tryptamines | 2004 |
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Topics: Animals; Cats; Cerebrovascular Circulation; Cranial Sinuses; Electric Stimulation; Gene Expression Regulation; Genes, fos; Migraine Disorders; Neurons, Afferent; Nociceptors; Oxazoles; Oxazolidinones; Pain; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Synaptic Transmission; Trigeminal Caudal Nucleus; Trigeminal Nerve; Trigeminal Nucleus, Spinal; Tryptamines; Vasoconstrictor Agents | 1998 |